Insiders · NRBO

NRBO insider transactions

NeuroBo Pharmaceuticals Inc. (NRBO) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for NRBO

• 548d
  CEO & President Kim Hyung Heon covered exercise/tax liability with 2,867 shares, decreasing direct ownership by 4% to 63,799 units (SEC Form 4)

  4 - MetaVia Inc. (0001638287) (Issuer)
• 621d
  Large owner Dong-A St Co., Ltd sold $1,526 worth of shares (407 units at $3.75), decreasing direct ownership by 0.01% to 5,347,792 units (SEC Form 4)

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 659d
  CEO & President Kim Hyung Heon covered exercise/tax liability with 11,467 shares, decreasing direct ownership by 15% to 66,666 units (SEC Form 4)

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 693d
  Amendment: Large owner Dong-A St Co., Ltd bought $10,000,003 worth of shares (2,544,530 units at $3.93), increasing direct ownership by 91% to 5,348,229 units (SEC Form 4)

  4/A - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 708d
  Large owner Dong-A St Co., Ltd bought $7,964,379 worth of shares (2,544,530 units at $3.13), increasing direct ownership by 91% to 5,348,229 units (SEC Form 4)

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 726d
  Salsbury Michael was granted 5,051 shares, increasing direct ownership by 40% to 17,552 units (SEC Form 4)

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 726d
  Groves Jason L was granted 5,051 shares, increasing direct ownership by 40% to 17,552 units (SEC Form 4)

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 726d
  Koven Andrew I was granted 5,051 shares, increasing direct ownership by 40% to 17,552 units (SEC Form 4)

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 726d
  Glickman Mark A was granted 5,051 shares, increasing direct ownership by 108% to 9,740 units (SEC Form 4)

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 726d
  Strickland D Gordon was granted 5,051 shares, increasing direct ownership by 40% to 17,552 units (SEC Form 4)

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 726d
  Tursi James Patrick was granted 5,051 shares, increasing direct ownership by 126% to 9,072 units (SEC Form 4)

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 821d
  Woodworth Marshall H was granted 33,496 shares (SEC Form 4)

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 912d
  Tursi James Patrick was granted 32,157 shares (SEC Form 4)

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 944d
  SEC Form 3 filed by new insider Tursi James Patrick

  3 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 947d
  SEC Form 3 filed by new insider Woodworth Marshall H

  3 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1024d
  SEC Form 4: Kim Hyung Heon was granted 625,064 shares

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1041d
  SEC Form 4 filed by Koven Andrew I

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1041d
  SEC Form 4 filed by Salsbury Michael

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1041d
  SEC Form 4 filed by Strickland D Gordon

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1041d
  SEC Form 4 filed by Groves Jason L

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1041d
  SEC Form 4 filed by Glickman Mark A

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1041d
  SEC Form 4 filed by Kim Na Yeon

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1041d
  SEC Form 4 filed by Kim Na Yeon (Amendment)

  4/A - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1118d
  SEC Form 3 filed by new insider Glickman Mark A

  3 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1232d
  SEC Form 3 filed by new insider Hooker Joseph

  3 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1289d
  SEC Form 3: New insider Goldman Sachs Group Inc claimed ownership of 1,220,502 shares

  3 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1406d
  SEC Form 4: E&Investment, Inc. disposed of 1,445,267 shares

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1406d
  SEC Form 4: Kim Na Yeon disposed of 1,445,267 shares

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1451d
  SEC Form 4 filed by Kim Na Yeon

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1451d
  SEC Form 4 filed by Groves Jason L

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1454d
  SEC Form 4 filed by Kim Hyung Heon

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1454d
  SEC Form 4 filed by Kang Richard

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1454d
  SEC Form 4 filed by Strickland D Gordon

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1454d
  SEC Form 4 filed by Salsbury Michael

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1454d
  SEC Form 4 filed by Koven Andrew I

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1582d
  SEC Form 4 filed by Strickland D Gordon

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1582d
  SEC Form 3 filed by new insider Strickland D Gordon

  3 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1672d
  SEC Form 4 filed by Price Ben Gil

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1672d
  SEC Form 3 filed by new insider Price Ben Gil

  3 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1734d
  SEC Form 4 filed by Koven Andrew I

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1780d
  SEC Form 3 filed by Kim Hyung Heon

  3 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1780d
  SEC Form 3 filed by KOVEN ANDREW I

  3 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)